Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study
<p>Abstract</p> <p>Background</p> <p>Dyslipidaemia is an important but modifiable risk factor of cardiovascular disease (CVD) in type 2 diabetes. Yet, the effectiveness of lipid regulating drugs in Asians is lacking. We examined the effects of lipid control and treatmen...
Main Authors: | Tong Peter CY, Kong Alice PS, Luk Andrea OY, Yu Linda WL, Yang Xilin, Ting Rose ZW, So Wing-Yee, Chan Juliana CN, Ma Ronald CW |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-11-01
|
Series: | Cardiovascular Diabetology |
Online Access: | http://www.cardiab.com/content/9/1/77 |
Similar Items
-
Hypoglycaemia, Abnormal Lipids, and Cardiovascular Disease among Chinese with Type 2 Diabetes
by: Yijun Li, et al.
Published: (2015-01-01) -
Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles
by: Elnaggar YS, et al.
Published: (2011-12-01) -
The Impact of Bioactive Lipids on Cardiovascular
Development
by: Alexander Kleger, et al.
Published: (2011-01-01) -
Lipid Measures and Cardiovascular Disease Prediction
by: Diederik F. van Wijk, et al.
Published: (2009-01-01) -
Genome-wide linkage scan for factors of metabolic syndrome in a Chinese population
by: Chan Juliana CN, et al.
Published: (2010-02-01)